Cargando…
Does chemotherapy improve survival in advanced breast cancer? A statistical overview.
The relative efficacies of cytotoxic chemotherapy regimens in the treatment of advanced breast cancer are generally assessed by comparing response rates in randomised trials. Treatment attempts to prolong survival but trials rarely demonstrate a statistically significant survival advantage: it has b...
Autores principales: | A'Hern, R. P., Ebbs, S. R., Baum, M. B. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1988
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246459/ https://www.ncbi.nlm.nih.gov/pubmed/3044434 |
Ejemplares similares
-
Chemotherapy and survival in advanced breast cancer: the inclusion of doxorubicin in Cooper type regimens.
por: A'Hern, R. P., et al.
Publicado: (1993) -
Combination or mild single agent chemotherapy for advanced breast cancer? CMF vs epirubicin measuring quality of life.
por: Fraser, S. C., et al.
Publicado: (1993) -
Breast cancer, prostaglandins and patient survival.
por: Bennett, A., et al.
Publicado: (1989) -
A daily diary for quality of life measurement in advanced breast cancer trials.
por: Fraser, S. C., et al.
Publicado: (1993) -
Childhood T-cell lymphoblastic lymphoma--does early resolution of mediastinal mass predict for final outcome? The United Kingdom Children's Cancer Study Group (UKCCSG).
por: Shepherd, S. F., et al.
Publicado: (1995)